SNOA 8-K 2026-06-18

Sonoma Pharmaceuticals, Inc. (SNOA) 8-K dated 2026-06-18 — accession 0001683168-26-004975. This URL is the filing, not the SNOA hub.

Sonoma Pharmaceuticals, Inc. (SNOA) is a drug manufacturers - specialty & generic company listed on US.

Sonoma Pharmaceuticals, Inc. filed a 8-K on 2026-06-18. Accession 0001683168-26-004975.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.

Not investment advice. The SNOA SEC hub lists recent forms. The stock page is the research view.